Skip to main content
. 2015 Sep 16;27(5):1426–1436. doi: 10.1681/ASN.2015040411

Figure 4.

Figure 4.

Fractional excretion of creatine and guanidinoacetate in individuals with and without the heterozygous p.Q215× MCT12 mutation. Fractional excretion of (A) creatine or (B) guanidinoacetate in individuals with (patients) and without (controls) MCT12 mutation. Fractional excretions were calculated using cystatin-C-based GFR estimates. Data are medians with interquartile range. FE, fractional excretion; NS, nonsignificant.